Related legislations
- Law no. 7/2003 - Foreign Trade Law
- Law no. 3/2016 - Amendment to Law no. 7/2003, Foreign Trade Law
- Law no. 11/2021 - Law on Pharmaceutical activities in the field of traditional Chinese medicine and registration of traditional Chinese medicines
- Law no. 12/2022 - Legal regime for the control of dangerous substances
- Administrative Regulation no. 28/2003 - Regulations on Foreign Trade Activities
- Administrative Regulation no. 19/2016 - Amendment to Administrative Regulation no. 28/2003 (Regulations on Foreign Trade Activities)
- Administrative Regulation no. 28/2016 - Nutrient Requirements for Infant Formulas
- Administrative Regulation no. 35/2021 - Organization and functioning of the Pharmaceutical Administration Bureau
- Administrative Regulation No. 46/2021 - Regulation of the Law on Pharmaceutical activities in the field of traditional Chinese medicine and registration of traditional Chinese medicines
- Administrative Regulation no. 27/2023 - Main regulation of the legal regime for the control of dangerous substances
- Technical Instruction of the Pharmaceutical Administration Bureau no 23/ISAF/2022 - Standard Specification for Heavy Metals and Toxic Elements, Microbiological Limits and Pesticide Residue Limits in Proprietary Chinese Medicines
- Technical Instruction of the Pharmaceutical Administration Bureau no 24/ISAF/2022 - Requirements for the registration of proprietary Chinese medicines with bovine origin
- Technical Instruction of the Pharmaceutical Administration Bureau no 27/ISAF/2022 - Requirements of the application for importation of Chinese medicinal ingredients, prepared portions of traditional Chinese medicines and extracts of products used in traditional Chinese medicines
- Chief Executive Dispatch no. 132/2001 - Regulation on the Import of Bezoar Antidotal Tablets (Niu Huang Chieh Tu Pien)
- Chief Executive Dispatch no. 120/2005 - Regulations on the Production and Import of Drugs Containing Bovine-Derived Substances
- Dispatch of the Chief Executive no. 244/2015 - Prohibition of the Import of Any Pharmaceutical Products Containing Both Corticosteroids and Nonsteroidal Anti-Inflammatory Substances
- Chief Executive Dispatch no. 209/2021 - List of Goods Authorised for Importation
- Chief Executive Dispatch no. 107/2023 - Defines the subcategorization and enumeration of dangerous substances
- Dispatch of the Secretary for Social Affairs and Culture no. 70/2008 - Lists of Prescription Medicines and Hospital-Only Medicines
- Dispatch of Health Bureau Director no. 6/SS/2004 - Prohibition of the Manufacture, Import and Sale of the Chinese Herbs Caulis Aristolochiae Manshuriensis (Guanmutong), Radix Aristolochiae Fangchi (Guangfangji), Radix Aristolochiae (Qingmuxiang) and their Pharmaceutical Preparations
- Dispatch of Health Bureau Director no. 47/SS/2009 - Documents Required for Import Licensing of Human Blood Products
- Dispatch of Health Bureau Director no. 04/SS/2021 - Documents Required for Import of New Drugs
- Technical Instruction of the Health Bureau no. 02/2000 - Documents Required for Import Licensing of Pharmaceutical Products
- Technical Instruction of the Health Bureau no. 01/2005 - Labelling Requirements on the Packaging of Radiopharmaceutical Products
- Technical Instruction of the Health Bureau no. 03/2005 - Labelling Requirements on the Packaging of Western Medicines
- Dispatch of the Secretary for Social Affairs and Culture no. 95/2021 - List of Chinese Medicinal Materials Adopted in Macao SAR
- Dispatch of the Secretary for Social Affairs and Culture no. 18/2024 - Approves the lists of medicines subject to veterinary prescription and medicines reserved for use in establishments of veterinary clinical care activities